ABSTRACT
PURPOSE: To compare the difference and agreement of axial length (AL) and anterior segment parameters obtained from the MYAH device with Pentacam AXL and IOLMaster 700 in myopic children. METHODS: The study included 60 eyes of 60 myopic children. AL, keratometry (K), and horizontal corneal diameter (CD) were measured with Pentacam AXL, IOLMaster 700, and MYAH, respectively. The Friedman test was used to assess the differences. The Intraclass Correlation Coefficient (ICC) and Bland-Altman plots were used to assess the consistency of measurements. RESULTS: The mean age was 10.2 ± 1.8 years (7-16 years). No statistically significant difference was determined between the Pentacam AXL, IOLMaster 700, and MYAH devices in terms of mean AL values (23.61 ± 1.42, 23.62 ± 1.45, 23.61 ± 1.42, respectively) (p = 0.06). The difference between devices in the mean steep K, flat K, mean K, and CD was statistically significant but clinically insignificant (steep K; 44.45 ± 1.25, 44.59 ± 1.23, 44.51 ± 1.24, flat K; 43.29 ± 1.28, 43.43 ± 1.29, 43.35 ± 1.30, mean K; 43.85 ± 1.21, 44.00 ± 1.19, 43.94 ± 1.20, and CD; 11.90 ± 0.34, 12.11 ± 0.38, 11.96 ± 0.31, respectively; p < 0.05). ICC and Bland-Altman plot analysis revealed a high correlation between the three devices in AL, steep K, flat K, mean K, and CD measurements. CONCLUSION: There was a quite good agreement between the MYAH, Pentacam AXL, and IOLMaster 700 devices regarding AL and anterior segment parameters. MYAH provides reliable measurements and will be a good option in the diagnosis of and follow-up with myopic children.
Subject(s)
Anterior Chamber , Myopia , Humans , Child , Biometry , Prospective Studies , Cornea/anatomy & histology , Myopia/diagnosis , Axial Length, Eye , Tomography, Optical Coherence , Reproducibility of ResultsABSTRACT
Simultaneous branch retinal artery and vein occlusion is a rare condition that may cause severe visual loss, and its treatment is often unrewarding. Herein, we report a case with simultaneous central retinal vein and branch retinal artery occlusion; it was successfully treated with a single dexamethasone intravitreal implant. The affected eye attained a visual acuity level of 20/25 from the visual acuity of hand motions at presentation with a residual, but relatively diminished, altitudinal scotoma during a follow-up period of 6 months.
ABSTRACT
The idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) syndrome is a disease characterized by multiple retinal macroaneurysms, neuroretinitis and peripheral capillary nonperfusion. Visual loss may result from either ischemia-related complications or macular involvement. Treatment is not always rewarding. We report a case with stage 2 IRVAN syndrome who was successfully treated with a single bilateral intravitreal dexamethasone implant in addition to panretinal photocoagulation and systemic azathioprine treatment.
ABSTRACT
Intravitreal anti-vascular endothelial growth factor (VEGF) agents seem to be effective in choroidal neovascular membranes (CNV) in association with various entities of posterior uveitis. We herein report a 46-year-old woman who was treated with a simultaneous single intravitreal dexamethasone implant and ranibizumab administration for the treatment of unilateral extrafoveal CNV associated with an active serpiginous choroiditis. Simultaneously with the intravitreal therapy, oral mycophenolic acid (2 × 720 mg) was started, and oral cyclosporine (3 × 100 mg) was then added 2 months later. On the other hand, the fellow eye had been treated for subfoveal CNV but with an inactive disease 4 years previously and ended up with a final visual acuity of counting fingers despite treatment with a single session of photodynamic therapy and 3 subsequent intravitreal ranibizumab injections. Simultaneous administration of anti-VEGF agents and a dexamethasone implant can be a viable approach in eyes with CNV and active serpiginous choroiditis.
